A redesigned immune-activating cancer drug has produced striking early results in a small clinical trial, shrinking tumors ...

Colorectal cancer breaks the usual immune rules, with certain regulatory T cells linked to improved survival. In many solid ...

Cancer has long remained a leading cause of death worldwide and in Hong Kong, accounting for 30% of all disease-related deaths in the city in 2025. While chemotherapy remains a major treatment ...

Immunotherapy has emerged in recent years as a new cancer treatment that is gentler than traditional chemotherapy and causes ...

Bile duct adenomas are benign tumors that grow inside the bile duct. They’re fairly rare and not usually a reason for concern. Sometimes, they may require treatment in case they become cancerous. Bile ...

Using nanotechnology, they developed nasal drops that travel along the nerves of the nose into the central nervous system to ...

USF medical engineering professors Dr. Richard Heller and Dr. Mark Jaroszeski have spent more than three decades developing a ...

A combination of two supplements — resveratrol and copper — reduced the aggressiveness of tumors in glioblastoma, a type of ...